Friday, 8 December 2023
  
Login

Australia's most trusted
source of pharma news

Friday, 8 December 2023
Ascott IQVIA
Ascott IQVIA
Latest News
BioNTech creating 1200 Aussie jobs

German giant BioNTech has fleshed out an agreement to open in Australia revealing the location for a new mRNA facility, an innovation centre, AI office and the creation of 1200 local jobs.

Death casts shadow over year end
ICYMI: The stories that topped this week
TODAY Your Week in Five Minutes
First out the door in '24?
Drugs line up for the first listings of the New Year
TODAY
PBS drug alert after Aussie deaths
Stronger warnings after TGA investigates serious AEs
TODAY
JPD
JPD
Most Popular
Chem Warehouse rumours swirl
Trading holt for Sigma - is the pharmacy giant going public?
7 December
TGA: See you in court
Proceedings initiated against business and former Director
7 December
Five new drugs hit review list
Anticipated blockbusters including another gene therapy
6 December
Top rewards for pharma stars
What's the best recognition a company can give for 'a job well done'?
6 December
Fleishman
Fleishman
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (4)

Sales & Customer Relations (14)

Clinical & Medical, R&D (6)

Regulatory, Pharmacovigilance & QA (7)

Executive Roles (2)

Other (25)

More News
AbbVie makes second bet in a week
Second multibillion dollar buyout deal in just seven days
TODAY
Last jobs of 2023 snapped up
Small flurry of appointments as year comes to a close
TODAY
Big pharma 'refreshes' brand
Upgrades look and tagline but keeps logo the same
7 December
J&J unveils mega 2030 plan
Suite of mega-blockbusters expected by the end of the decade
7 December
Blockbuster to crack new market
Already huge drug expanding into untapped space
7 December
Future in doubt for patient group
Founder says high-profile organisation is winding up
7 December
Simply the best in Medical Affairs
MAPA Excellence Award winners 2023 reavealed
6 December
Another win for KRAS drug
Aussie-led study shows combo potential in big market
6 December
Why Novartis is sitting pretty
Which fast-growing meds have pumped up revenue?
6 December
Real reform or window dressing?
NZ's Pharmac facing change but funding problem remains
6 December
How flexible is your pharma?
How working conditions stack up across the industry
5 December
Roche takes a shot in obesity
Buys best-in-class potential for mega-market
5 December
Pharmacy behaviours unpacked
New report reveals drop in pharmacy visits this year
5 December
Familiar face joins MA Board
This top ex-public servant brings decades of Govt experience
5 December
PIF xmas
PIF xmas
© 2003 - 2023 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe